Abstract
Purpose
A retained placenta after vaginal delivery where manual removal of placenta fails is a clinical challenge. We present six cases that illustrate the heterogeneity of the condition and discuss the etiology and terminology as well as the clinical management.
Methods
Members of the European Working group on Abnormally Invasive Placenta (EW-AIP) were invited to report all recent cases of retained placenta that were not antenatally suspected to be abnormally adherent or invasive, but could not be removed manually despite several attempts.
Results
The six cases from Denmark, The Netherlands and the UK provide examples of various treatment strategies such as ultrasound-guided vaginal removal, removal of the placenta through a hysterotomy and just leaving the placenta in situ. The placentas were all retained, but it was only possible to diagnose abnormal invasion in the one case, which had a histopathological diagnosis of increta. Based on these cases we present a flow chart to aid clinical management for future cases.
Conclusion
We need properly defined stringent terminology for the different types of retained placenta, as well as improved tools to predict and diagnose both abnormally invasive and abnormally adherent placenta. Clinicians need to be aware of the options available to them when confronted by the rare case of a retained placenta that cannot be removed manually in a hemodynamically stable patient.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00404-017-4579-2/MediaObjects/404_2017_4579_Fig1_HTML.gif)
Similar content being viewed by others
References
Evensen A, Anderson JM, Fontaine P (2017) Postpartum hemorrhage: prevention and treatment. Am Fam Physician 95(7):442–449
Herman A (2000) Complicated third stage of labor: time to switch on the scanner. Ultrasound Obstet Gynecol 15(2):89–95
Collins SL, Stevenson GN, Al-Khan A, Illsley NP, Impey L, Pappas L et al (2015) Three-dimensional power Doppler ultrasonography for diagnosing abnormally invasive placenta and quantifying the risk. Obstet Gynecol 126(3):645–653
Bennett MJ, Townsend L (2009) Conservative management of clinically diagnosed placenta accreta following vaginal delivery. Aust N Z J Obstet Gynaecol 49(6):647–649
Lee D, Johnson J (2012) Hysterotomy for retained placenta in a septate uterus: a case report. Case Rep Obstet Gynecol 2012:594140
Shekhar S, Verma S, Motey R, Kaushal R (2010) Hysterotomy for retained placenta with imminent uterine rupture in a preterm angular pregnancy. Acta Obstet Gynecol Scand 89(12):1615–1616
Silver RM, Barbour KD (2015) Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am 42(2):381–402
Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F et al (2010) Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 115(3):526–534
Chongsomchai C, Lumbiganon P, Laopaiboon M (2014) Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Cochrane Database Syst Rev 10:CD004904
Endler M, Grunewald C, Saltvedt S (2012) Epidemiology of retained placenta: oxytocin as an independent risk factor. Obstet Gynecol 119(4):801–809
Owolabi AT, Dare FO, Fasubaa OB, Ogunlola IO, Kuti O, Bisiriyu LA (2008) Risk factors for retained placenta in southwestern Nigeria. Singap Med J 49(7):532–537
Adelusi B, Soltan MH, Chowdhury N, Kangave D (1997) Risk of retained placenta: multivariate approach. Acta Obstet Gynecol Scand 76(5):414–418
Combs CA, Laros RK Jr (1991) Prolonged third stage of labor: morbidity and risk factors. Obstet Gynecol 77(6):863–867
Coviello EM, Grantz KL, Huang CC, Kelly TE, Landy HJ (2015) Risk factors for retained placenta. Am J Obstet Gynecol 213(6):864 e1–864 e11
Ashwal E, Melamed N, Hiersch L, Wiznitzer A, Yogev Y, Peled Y (2014) The incidence and risk factors for retained placenta after vaginal delivery—a single center experience. J Matern Fetal Neonatal Med 27(18):1897–1900
Belachew J, Cnattingius S, Mulic-Lutvica A, Eurenius K, Axelsson O, Wikstrom AK (2014) Risk of retained placenta in women previously delivered by caesarean section: a population-based cohort study. BJOG 121(2):224–229
Panpaprai P, Boriboonhirunsarn D (2007) Risk factors of retained placenta in Siriraj Hospital. J Med Assoc Thai 90(7):1293–1297
Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N, Coomarasamy A (2011) The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Hum Reprod Update 17(6):761–771
Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ (2011) Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol 38(4):371–382
Fox NS, Roman AS, Stern EM, Gerber RS, Saltzman DH, Rebarber A (2014) Type of congenital uterine anomaly and adverse pregnancy outcomes. J Matern Fetal Neonatal Med 27(9):949–953
Hiersch L, Yeoshoua E, Miremberg H, Krissi H, Aviram A, Yogev Y et al (2016) The association between Mullerian anomalies and short-term pregnancy outcome. J Matern Fetal Neonatal Med 29(16):2573–2578
Vaz SA, Dotters-Katz SK, Kuller JA (2017) Diagnosis and management of congenital uterine anomalies in pregnancy. Obstet Gynecol Surv 72(3):194–201
Wright CE, Chauhan SP, Abuhamad AZ (2014) Bakri balloon in the management of postpartum hemorrhage: a review. Am J Perinatol 31(11):957–964
Doumouchtsis SK, Papageorghiou AT, Arulkumaran S (2007) Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 62(8):540–547
Georgiou C (2009) Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 116(6):748–757
Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M (2011) Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG 118(7):856–864
Laas E, Bui C, Popowski T, Mbaku OM, Rozenberg P (2012) Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. Am J Obstet Gynecol. 207(4):281 e1–281 e7
Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg P (2016) Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG 124(8):1255–1262. doi:10.1111/1471-0528.14382
D’Antonio F, Palacios-Jaraquemada J, Lim PS, Forlani F, Lanzone A, Timor-Tritsch I et al (2016) Counseling in fetal medicine: evidence-based answers to clinical questions on morbidly adherent placenta. Ultrasound Obstet Gynecol 47(3):290–301
Ruiz Labarta FJ, Pintado Recarte MP, Alvarez Luque A, Joigneau Prieto L, Perez Martin L, Gonzalez Leyte M et al (2016) Outcomes of pelvic arterial embolization in the management of postpartum haemorrhage: a case series study and systematic review. Eur J Obstet Gynecol Reprod Biol 206:12–21
Cirpan T, Sanhal CY, Yucebilgin S, Ozsener S (2011) Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy. J Turk Ger Gynecol Assoc 12(2):127–129
Heiskanen N, Kroger J, Kainulainen S, Heinonen S (2008) Placenta percreta: methotrexate treatment and MRI findings. Am J Perinatol 25(2):91–92
Lalchandani S, Geary M, O’Herlihy C, Sheil O (2003) Conservative management of placenta accreta and unruptured interstitial cornual pregnancy using methotrexate. Eur J Obstet Gynecol Reprod Biol 107(1):96–97
Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA (2000) Placenta accreta and methotrexate therapy: three case reports. J Perinatol 20(5):331–334
Pinho S, Sarzedas S, Pedroso S, Santos A, Rebordao M, Avillez T et al (2008) Partial placenta increta and methotrexate therapy: three case reports. Clin Exp Obstet Gynecol 35(3):221–224
Lim BH, Palacios-Jaraquemada JM (2015) The morbidly adherent placenta—a continuing diagnostic and management challenge. BJOG 122(12):1673
Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V (2011) Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand 90(10):1140–1146
Bhide A, Sebire N, Abuhamad A, Acharya G, Silver R (2017) Morbidly adherent placenta: the need for standardization. Ultrasound Obstet Gynecol 49(5):559–563
Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadottir RI et al (2016) Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 123(8):1348–1355
Author information
Authors and Affiliations
Consortia
Contributions
The authors all take responsibility for the paper as published. JB: protocol/project development, data collection, manuscript writing. SC: data collection, manuscript editing. JL-R: protocol/project development, data collection, manuscript editing. KS: data collection, manuscript editing. AJ: data collection, manuscript editing. JJD: protocol/project development, data collection, manuscript editing. LG: protocol/project development, data collection, manuscript editing.
Corresponding author
Ethics declarations
Funding
This study received no funding.
Conflict of interest
The authors declare that they have no conflicts of interests to disclose.
Ethical approval
Informed consent to publish patient histories in an anonymous form was obtained from all six patients included. Therefore, approval from national ethics committees is not needed.
Additional information
The European Working group on Abnormally Invasive Placenta, EW-AIP, is a collaboration from 11 European university hospitals working in the field of abnormally invasive placentation. The EW-AIP was founded in 2008, their website is at http://www.ew-aip.org.
Rights and permissions
About this article
Cite this article
Bjurström, J., Collins, S., Langhoff-Roos, J. et al. Failed manual removal of the placenta after vaginal delivery. Arch Gynecol Obstet 297, 323–332 (2018). https://doi.org/10.1007/s00404-017-4579-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-017-4579-2